Evaluation of Ibrutinib Cardiotoxicity By Comparative Use of Speckle-Tracking Technique and Biomarkers
Sign Up to like & getrecommendations! Published in 2022 at "American Journal of Therapeutics"
DOI: 10.1097/mjt.0000000000001463
Abstract: Background: Ibrutinib, a relatively new antineoplastic agent, has multiple cardiovascular effects that are still insufficiently known and evaluated, including subclinical myocardial damage. Study Question: The present study aims to assess the role of the myocardial… read more here.
Keywords: increase; myocardial strain; ibrutinib cardiotoxicity; cardiotoxicity ... See more keywords